Tag: Interest

DRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the U.S. Sales of Veligrotug and VRDN-003 for the Treatment of Thyroid Eye Disease (TED)
Eye Healthcare

DRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the U.S. Sales of Veligrotug and VRDN-003 for the Treatment of Thyroid Eye Disease (TED)

January 2, 2026
admin

–Third synthetic royalty transaction & second pre-approval deal for DRI – – Further increases portfolio exposure…

Continue Reading